CL2012000234A1 - Suplemento nutricional para lactantes o mascotas alimentados con leche materna, que comprende al menos un probiotico y al menos un nutriente seleccionado de entre los mas variables en la leche maternal humana; su uso; y metodo de preparacion. - Google Patents

Suplemento nutricional para lactantes o mascotas alimentados con leche materna, que comprende al menos un probiotico y al menos un nutriente seleccionado de entre los mas variables en la leche maternal humana; su uso; y metodo de preparacion.

Info

Publication number
CL2012000234A1
CL2012000234A1 CL2012000234A CL2012000234A CL2012000234A1 CL 2012000234 A1 CL2012000234 A1 CL 2012000234A1 CL 2012000234 A CL2012000234 A CL 2012000234A CL 2012000234 A CL2012000234 A CL 2012000234A CL 2012000234 A1 CL2012000234 A1 CL 2012000234A1
Authority
CL
Chile
Prior art keywords
breast milk
probiotic
variable
preparation
infants
Prior art date
Application number
CL2012000234A
Other languages
English (en)
Spanish (es)
Inventor
Degonda Gabriela Bergonzelli
Franz Isabelle Bureau
Rodenas Clara Lucia Garcia
Corinne Magliola
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41259077&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2012000234(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of CL2012000234A1 publication Critical patent/CL2012000234A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/48—Moist feed
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Diabetes (AREA)
  • Pediatric Medicine (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
CL2012000234A 2009-07-31 2012-01-30 Suplemento nutricional para lactantes o mascotas alimentados con leche materna, que comprende al menos un probiotico y al menos un nutriente seleccionado de entre los mas variables en la leche maternal humana; su uso; y metodo de preparacion. CL2012000234A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09166969 2009-07-31

Publications (1)

Publication Number Publication Date
CL2012000234A1 true CL2012000234A1 (es) 2012-09-28

Family

ID=41259077

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2012000234A CL2012000234A1 (es) 2009-07-31 2012-01-30 Suplemento nutricional para lactantes o mascotas alimentados con leche materna, que comprende al menos un probiotico y al menos un nutriente seleccionado de entre los mas variables en la leche maternal humana; su uso; y metodo de preparacion.

Country Status (14)

Country Link
US (1) US20120121562A1 (enExample)
EP (1) EP2459202A1 (enExample)
CN (1) CN102481323A (enExample)
AU (1) AU2010277582A1 (enExample)
BR (1) BR112012002223A2 (enExample)
CA (1) CA2767960A1 (enExample)
CL (1) CL2012000234A1 (enExample)
IN (1) IN2012DN00282A (enExample)
MX (1) MX2012001362A (enExample)
RU (1) RU2012107695A (enExample)
SG (1) SG177541A1 (enExample)
TW (1) TW201117818A (enExample)
WO (1) WO2011012655A1 (enExample)
ZA (1) ZA201201471B (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2708924T3 (es) 2010-12-31 2019-04-12 Abbott Lab Procedimientos de uso de oligosacáridos de la leche humana para mejorar la salud respiratoria de las vías respiratorias
ES2719404T5 (es) 2010-12-31 2024-09-18 Abbott Lab Composiciones nutricionales que comprenden oligosacáridos de leche humana para el uso en el tratamiento y/o prevención de la infección por rotavirus entérico
CN103369974A (zh) 2010-12-31 2013-10-23 雅培制药有限公司 包含人乳低聚糖和长链多不饱和脂肪酸的营养型制剂以及其用途
US9795623B2 (en) 2010-12-31 2017-10-24 Abbott Laboratories Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin C and anti-inflammatory agents
US9283240B2 (en) 2010-12-31 2016-03-15 Abbott Laboratories Human milk oligosaccharides for modulating inflammation
SG191393A1 (en) 2010-12-31 2013-08-30 Abbott Lab Neutral human milk oligosaccharides to promote growth of beneficial bacteria
SG10201603856PA (en) 2010-12-31 2016-07-28 Abbott Lab Methods For Decreasing The Incidence Of Necrotizing Enterocolitis In Infants, Toddlers, Or Children Using Human Milk Oligosaccharides
CN102106463B (zh) * 2011-01-31 2012-12-05 杨永浩 一种微生物饲料添加剂及其制备方法
CN104126749A (zh) * 2011-02-10 2014-11-05 雀巢产品技术援助有限公司 使用人乳中发现的特定量的寡糖的组合调节双歧杆菌属的生长
ITMI20111488A1 (it) * 2011-08-03 2013-02-04 Gnosis Spa Formulazioni comprendenti saccharomyces boulardii e superossido dismutasi (sod) per controllare l'obesita'
CN104023560A (zh) 2011-08-29 2014-09-03 雅培制药有限公司 用于预防胃肠道损伤和/或促进胃肠道愈合的人乳寡糖
WO2013057062A1 (en) * 2011-10-18 2013-04-25 Nestec S.A. Composition for use in the promotion of intestinal angiogenesis and of nutrient absorption and of enteral feeding tolerance and/or in the prevention and/or treatment of intestinal inflammation and/or in the recovery after intestinal injury and surgery
PT2775852T (pt) * 2011-10-18 2016-11-08 Nestec Sa Composição para utilização no crescimento cerebral e/ou desenvolvimento cognitivo e/ou psicomotor
KR101166798B1 (ko) * 2011-12-19 2012-07-26 김대현 락토바실러스 애시도필러스 엘비의 사균을 포함하는 알레르기 질환의 치료 또는 예방용 의약 조성물
UA118339C2 (uk) * 2012-09-03 2019-01-10 Біогайа Аб Бактеріальний штам lactobacillus gasseri для лікування порушення моторики кишечнику (варіанти)
WO2014062683A1 (en) * 2012-10-15 2014-04-24 University Of Florida Research Foundation, Inc. Materials and methods for prevention and treatment of diarrhea and inflammation in the gastrointestinal tract
US11179427B2 (en) 2013-01-21 2021-11-23 Eth Zurich Baby food composition comprising viable propionic acid-producing bacteria
SG11201607831TA (en) 2014-03-26 2016-10-28 Abbott Lab Nutritional supplement powder
WO2015176229A1 (en) * 2014-05-20 2015-11-26 Nestle (China) Ltd. Delivery mode specific synthetic nutritional compositions and nutritional systems comprising them
MX2017010923A (es) * 2015-03-05 2018-01-16 Nestec Sa Composiciones para usar en el mejoramiento de la consistencia o la frecuencia de las heces en infantes o niños pequeños.
WO2016183535A1 (en) 2015-05-14 2016-11-17 University Of Puerto Rico Methods for restoring microbiota of newborns
CN105030843A (zh) * 2015-06-18 2015-11-11 陈英扬 罗伊氏乳杆菌滴剂及其制备方法
MX2018001849A (es) * 2015-08-31 2018-05-16 Nestec Sa Metodos y composiciones que usan bifidobacterium longum para modular la reactividad emocional y tratar o prevenir perturbaciones subclinicas del estado de animo.
BR122022002030B1 (pt) 2015-12-14 2023-05-16 Société des Produits Nestlé S.A. Composição nutricional sintética, seu uso e vitamina
US11564667B2 (en) 2015-12-28 2023-01-31 New York University Device and method of restoring microbiota of newborns
US10912323B2 (en) 2016-02-29 2021-02-09 Abbott Laboratories Nutritional supplement powder
KR101938865B1 (ko) * 2016-11-03 2019-01-16 주식회사 쎌바이오텍 골 질환, 비만 및 지질 관련 대사성 질환의 예방 또는 치료용 조성물
WO2018215573A1 (en) * 2017-05-24 2018-11-29 Nestec S.A. Composition comprising oligofructose (of) for use in the improvement of short term memory and other cognitive benefits
BR112019028039A2 (pt) * 2017-06-30 2020-07-07 N.V. Nutricia composição nutricional, uso de uma combinação de bifidobacterium breve e oligossacarídeos não digeríveis, e método para prevenir e/ou reduzir o risco de ocorrência de hiperinsulinemia
US11524019B2 (en) 2017-08-21 2022-12-13 Glycom A/S Synthetic composition for reducing allergy symptoms
CN108823125A (zh) * 2018-06-13 2018-11-16 山东巴元生物科技有限公司 一种治疗睡眠障碍益生菌制剂的生产方法及应用
WO2020033708A1 (en) * 2018-08-08 2020-02-13 Mars, Incorporated Pet food products comprising oligosaccharides and methods of use
MX2021006185A (es) * 2018-12-21 2021-08-16 Nestle Sa Combinacion de probioticos para el tratamiento de trastornos alergicos.
US20210352925A1 (en) * 2019-02-04 2021-11-18 N.V. Nutricia Fermented formula with non digestible oligosaccharides for sleep improvement
KR102188765B1 (ko) * 2019-06-12 2020-12-08 정옥숙 애완동물용 동결건조파우더 및 이의 제조방법
CN112868800A (zh) * 2019-11-29 2021-06-01 内蒙古伊利实业集团股份有限公司 含母乳低聚糖提高免疫力的婴幼儿配方奶粉及其制备方法
EP4065146A1 (en) * 2019-11-29 2022-10-05 Société des Produits Nestlé S.A. Compositions and methods with a probiotic and a nutrient and/or mineral for the prevention or treatment of mastitis
CN118019459A (zh) * 2021-09-28 2024-05-10 雀巢产品有限公司 使用的组合物

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3936799C1 (enExample) * 1989-11-04 1991-01-10 Deutsche Atochem Werke Gmbh, 5300 Bonn, De
FR2714574B1 (fr) * 1993-12-31 1996-03-15 Inst Rech Biolog Sa Nouveaux suppléments alimentaires pour la nutrition des très jeunes enfants.
US7033629B2 (en) * 2001-08-31 2006-04-25 Nutricopia Inc. Nutritional frozen dessert and methods of manufacture
EP1638415B1 (en) * 2003-06-23 2010-12-15 Nestec S.A. Infant or follow-on formula
NZ544726A (en) * 2003-06-23 2009-05-31 Nestec Sa Infant or follow-on formula
JP2008500271A (ja) * 2003-10-14 2008-01-10 ザ・プロウボウスト・フェロウズ・アンド・スカラーズ・オブ・ザ・カレッジ・オブ・ザ・ホリー・アンド・アンデバイデッド・トリニティ・オブ・クイーン・エリザベス・ニア・ダブリン 免疫介在性疾患の治療および／または予防におけるアデニル酸シクラーゼ
US7862808B2 (en) * 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
ATE526836T1 (de) * 2005-02-28 2011-10-15 Nutricia Nv Nährstoffzusammensetzung mit probiotika
US20060251634A1 (en) * 2005-05-06 2006-11-09 Ho-Jin Kang Method of improving immune function in mammals using lactobacillus strains with certain lipids
US20070059297A1 (en) * 2005-08-04 2007-03-15 Nestec, S.A. Methods and compositions for improving visual acuity
ES2334943T3 (es) * 2005-10-05 2010-03-17 Nestec S.A. Uso de una formulacion nutritiva para fomentar la recuperacion del crecimiento.
WO2007126990A2 (en) * 2006-03-29 2007-11-08 Nestec S.A. Dietary supplements containing probiotics
US7374924B2 (en) 2006-06-05 2008-05-20 Biogaia Ab Use of selected lactic acid bacteria for reducing infantile colic
NL1033521C2 (nl) * 2007-03-08 2008-09-09 Friesland Brands Bv Kindervoedingen met geoptimaliseerde aminozuursamenstelling.
EP1974743A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Probiotics to Improve Gut Microbiota
EP1974734A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Probiotics for reduction of risk of obesity
US20090118228A1 (en) * 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
WO2009079544A1 (en) * 2007-12-17 2009-06-25 University Of Florida Research Foundation, Inc. Materials and methods for treatment of pathological ocular vascular proliferation
MX2011002982A (es) * 2008-09-19 2011-04-11 Nestec Sa Soporte nutricional del sistema inmunologico durante el tratamiento anti-cancer.

Also Published As

Publication number Publication date
EP2459202A1 (en) 2012-06-06
SG177541A1 (en) 2012-02-28
TW201117818A (en) 2011-06-01
RU2012107695A (ru) 2013-09-10
CN102481323A (zh) 2012-05-30
ZA201201471B (en) 2014-08-27
CA2767960A1 (en) 2011-02-03
IN2012DN00282A (enExample) 2015-05-08
BR112012002223A2 (pt) 2016-06-07
MX2012001362A (es) 2012-02-22
WO2011012655A1 (en) 2011-02-03
US20120121562A1 (en) 2012-05-17
AU2010277582A1 (en) 2012-02-02

Similar Documents

Publication Publication Date Title
CL2012000234A1 (es) Suplemento nutricional para lactantes o mascotas alimentados con leche materna, que comprende al menos un probiotico y al menos un nutriente seleccionado de entre los mas variables en la leche maternal humana; su uso; y metodo de preparacion.
AR111298A2 (es) Producto alimenticio que comprende una biomasa de traustoquítridos
MX2019011510A (es) Metodos y composiciones para mejorar la salud.
CU20170030A7 (es) Sacáridos y mezclas y composiciones de sacáridos
UY33405A (es) Composiciones y bebidas que comprenden nutrientes, vitaminas, azúcares, cisteína y/o productos de azúcar-cisteína
CL2011002083A1 (es) Preparado proteico a partir de semillas de colza, con contenido de proteinas menor a 90%, en que el preparado tiene funcionalidad ligadora de agua, ligadora de aceite y emulsionante; procedimiento de obtencion del preparado proteico; su uso; y procedimiento de utilizacion energetica de las cascaras.
AR060387A1 (es) Suplementos alimenticios y sus usos
ECSP13011139A (es) Anticuerpos contra la angiopoyetina 2 humana
BRPI0511391A (pt) preparação de prebiótico
PH12012502314A1 (en) Tube feed packages and methods for using same
CL2012000803A1 (es) Complejo que comprende un almidon que contiene un almidon con un contenido de almidon resistente de por lo menos 70% (p/p) y un hidrocoloide; proceso para elaborar el complejo que comprende mezclar almidon e hidrocoloide, hidratar la mzcla seca en el extrusor con agua, extruir para formar el complejo: alimenticio que comprende el complejo; metodo para incrementar la saciedad que comprende el consumo del complejo; uso del complejo.
MX2018000958A (es) Composiciones nutritivas y formulas infantiles que comprenden bifidobacterium animalis ssp.lactis y, opcionalmente, una mezcla de oligosacaridos para inducir una microbiota intestinal cercana a la de un infante alimentado por lactancia materna.
MX2011012741A (es) Un suplemento que comprende grosellas negras o moras grandes.
MX393921B (es) Ingredientes de pienso que comprenden células microbianas lisadas.
MY161614A (en) Improved nutritional tablet
MX2012007587A (es) Composiciones nutricionales que comprenden hojuelas de frutas que incluyen acido docosahexaenoico.
AR078388A1 (es) Producto lacteo pasteurizado y fermentado, y procedimiento para su preparacion
PH12020550653A1 (en) Synthetic nutritional compositions tailored for infants of specific ages, and nutritional systems comprising them
MX2011011559A (es) Parasiticidas sanguineos.
CL2013003225A1 (es) Sistema de agente de control biológico (bca) que comprende momias de chanchitos blancos de la familia pseudococcidae, desprovistos de extremidades y cubierta cerosa, los cuales están parasitados por avispas endo-parasitarias; método para producir dicho sistema de bca; método para controlar infestaciones de chanchitos blancos en plantas; y producto.
PH12018500164A1 (en) Gender specific synthetic nutritional compositions and nutritional systems comprising them
MX2018001924A (es) Composiciones nutritivas sinteticas adaptadas para infantes de edades especificas, y sistemas nutritivos que las comprenden.
PH12020550026A1 (en) Gender specific synthetic nutritional compositions and nutritional systems comprising them
REFERENCIAL 2.1 MARCO NORMATIVO.
AR058980A1 (es) Composicion para el cuidado de telas